STOCK TITAN

[SCHEDULE 13D/A] Apimeds Pharmaceuticals US, Inc. Amended Major Shareholder Report

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A





03771D102

(CUSIP Number)
You In Soo CEO
Room 613, Digital-ro 130, 6F Geumcheon-gu
Seol, M5, 08580
82-70-7600-7007

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
03/20/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The percentage in Row 13 is based on 12,575,983 shares of common stock, par value $0.01 per share (the "Common Stock"), of Apimeds Pharmaceuticals US, Inc., a Delaware corporation (the "Issuer") outstanding as of February 26, 2026, as reported by the Issuer in its Definitive Proxy Statement on Schedule 14C filed on February 27, 2026 (the "Definitive 14C").


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The percentage in Row 13 is based on 12,575,983 shares of Common Stock outstanding as of February 26, 2026, as reported by the Issuer in the Definitive 14C


SCHEDULE 13D


Inscobee Inc.
Signature:/s/ You In Soo
Name/Title:You In Soo, Chief Executive Officer
Date:03/20/2026
Apimeds Inc.
Signature:/s/ You In Soo
Name/Title:You In Soo, Chief Executive Officer
Date:03/20/2026
APIMEDS PHARMACEUTICALS US INC

NYSE:APUS

View APUS Stock Overview

APUS Rankings

APUS Latest News

APUS Latest SEC Filings

APUS Stock Data

24.52M
3.09M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United Arab Emirates
MATAWAN